glp-1 supply chain news Agonists Market Exclusive Research Report 2025 The GLP-1 boom: Challenges, trends,
Description
*** This was reported as a composite of death from cardiovascular causes and hospital admission for heart failure
Given the low circulating and tissue levels of most DPP-4 substrates and the technical challenge inherent in quantifying intact versus cleaved peptides, it seems likely that some DPP-4 substrates currently classified as pharmacological may one day also be found to be cleaved by DPP-4 in vivo [20]
doi:10.1056/NEJMoa2107519
A big salad may be beautiful, but still too much volume
Thats a major exit path and strategic investor presence
Hepatology 24 (2), 289293 (1996)
